Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma

Zhang, Peng; Cao, Fang; Zhang, Jiqin; Tan, Ying; Yao, Shengtao

doi:10.1016/j.heliyon.2023.e18490

Cited by 6 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are studies on loading chemotherapeutic drugs such as cisplatin [ 184 , 185 ], sorafenib [ 186 , 187 ], temozolomide [ 188 , 189 ], 5-fluorouracil [ 190 , 191 , 192 ], irinotecan [ 193 , 194 ], and epirubicin [ 120 , 159 ]. This is just a small list of examples of anticancer drugs that can be encapsulated in nanoparticle MSNs for cancer treatment.…”

Section: Antitumour Drugs In Mesoporous-silica-based Delivery Systemsmentioning

confidence: 99%

Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs

Kovtareva,

Kusepova,

Tazhkenova

et al. 2024

Polymers

View full text Add to dashboard Cite

The problem of tumour therapy has attracted the attention of many researchers for many decades. One of the promising strategies for the development of new dosage forms to improve oncology treatment efficacy and minimise side effects is the development of nanoparticle-based targeted transport systems for anticancer drugs. Among inorganic nanoparticles, mesoporous silica deserves special attention due to its outstanding surface properties and drug-loading capability. This review analyses the various factors affecting the cytotoxicity, cellular uptake, and biocompatibility of mesoporous silica nanoparticles (MSNs), constituting a key aspect in the development of safe and effective drug delivery systems. Special attention is paid to technological approaches to chemically modifying MSNs to alter their surface properties. The stimuli that regulate drug release from nanoparticles are also discussed, contributing to the effective control of the delivery process in the body. The findings emphasise the importance of modifying MSNs with different surface functional groups, bio-recognisable molecules, and polymers for their potential use in anticancer drug delivery systems.

show abstract